321 related articles for article (PubMed ID: 31494053)
1. Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors.
Li C; Mishra AS; Gil S; Wang M; Georgakopoulou A; Papayannopoulou T; Hawkins RD; Lieber A
Mol Ther; 2019 Dec; 27(12):2195-2212. PubMed ID: 31494053
[TBL] [Abstract][Full Text] [Related]
2. In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model.
Li C; Wang H; Georgakopoulou A; Gil S; Yannaki E; Lieber A
Mol Ther; 2021 Feb; 29(2):822-837. PubMed ID: 32949495
[TBL] [Abstract][Full Text] [Related]
3. A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.
Wang H; Lieber A
J Virol; 2006 Dec; 80(23):11699-709. PubMed ID: 16987973
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.
Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A
Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357
[TBL] [Abstract][Full Text] [Related]
5. Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements.
Wang H; Georgakopoulou A; Li C; Liu Z; Gil S; Bashyam A; Yannaki E; Anagnostopoulos A; Pande A; Izsvák Z; Papayannopoulou T; Lieber A
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814708
[TBL] [Abstract][Full Text] [Related]
6. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia.
Wang H; Georgakopoulou A; Psatha N; Li C; Capsali C; Samal HB; Anagnostopoulos A; Ehrhardt A; Izsvák Z; Papayannopoulou T; Yannaki E; Lieber A
J Clin Invest; 2019 Feb; 129(2):598-615. PubMed ID: 30422819
[TBL] [Abstract][Full Text] [Related]
7. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
[TBL] [Abstract][Full Text] [Related]
8. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
9. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
[TBL] [Abstract][Full Text] [Related]
10. Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies.
Li C; Psatha N; Wang H; Singh M; Samal HB; Zhang W; Ehrhardt A; Izsvák Z; Papayannopoulou T; Lieber A
Mol Ther Methods Clin Dev; 2018 Jun; 9():142-152. PubMed ID: 29766024
[TBL] [Abstract][Full Text] [Related]
11. In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4.
Wang H; Germond A; Li C; Gil S; Kim J; Kiem HP; Lieber A
Blood Adv; 2022 Aug; 6(15):4360-4372. PubMed ID: 35679480
[TBL] [Abstract][Full Text] [Related]
12. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
Heister T; Heid I; Ackermann M; Fraefel C
J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
[TBL] [Abstract][Full Text] [Related]
14. High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells.
Wang H; Liu Z; Li C; Gil S; Papayannopoulou T; Doering CB; Lieber A
Blood Adv; 2019 Oct; 3(19):2883-2894. PubMed ID: 31585952
[TBL] [Abstract][Full Text] [Related]
15. HDAd6/35++ - A new helper-dependent adenovirus vector platform for
Wang H; Georgakopoulou A; Zhang W; Kim J; Gil S; Ehrhardt A; Lieber A
Mol Ther Methods Clin Dev; 2023 Jun; 29():213-226. PubMed ID: 37081854
[TBL] [Abstract][Full Text] [Related]
16. A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.
Wang H; Shayakhmetov DM; Leege T; Harkey M; Li Q; Papayannopoulou T; Stamatoyannopolous G; Lieber A
J Virol; 2005 Sep; 79(17):10999-1013. PubMed ID: 16103151
[TBL] [Abstract][Full Text] [Related]
17. HDAd5/35
Li C; Psatha N; Gil S; Wang H; Papayannopoulou T; Lieber A
Mol Ther Methods Clin Dev; 2018 Jun; 9():390-401. PubMed ID: 30038942
[TBL] [Abstract][Full Text] [Related]
18. Differential Transgene Silencing of Myeloid-Specific Promoters in the
Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
[TBL] [Abstract][Full Text] [Related]
19. Safe and efficient
Li C; Wang H; Gil S; Germond A; Fountain C; Baldessari A; Kim J; Liu Z; Georgakopoulou A; Radtke S; Raskó T; Pande A; Chiang C; Chin E; Yannaki E; Izsvák Z; Papayannopoulou T; Kiem HP; Lieber A
Mol Ther Methods Clin Dev; 2022 Mar; 24():127-141. PubMed ID: 35036470
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration.
Zhang C; Cortez NG; Berns KI
Hum Gene Ther; 2007 Sep; 18(9):787-97. PubMed ID: 17760515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
